Prevalence of Unrecognized Dyslipidaemia in Dubai and Northern Emirates: A Cross-Sectional Hospital Based Study

被引:0
作者
Vela, Barbara Karin [1 ]
Alhessi, Alaaeldin Y. [2 ]
Popovic, Marko [3 ]
Al-Shaqra, Maryam A. [4 ]
机构
[1] Dubai London Clin, Dubai, U Arab Emirates
[2] Emirates Hosp, Dubai, U Arab Emirates
[3] Vipnet, Zagreb, Croatia
[4] Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates
关键词
dyslipidaemia; LDL cholesterol; HDL cholesterol; prevalence; United Arab Emirates;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
The aim of this study is to determine the prevalence of unrecognized dyslipidaemia and a specific correlation between lipid values and age, gender or ethnic origin in the study population. This retrospective cross-sectional study included 311 subjects who had their lipid profiles checked for the first time in a private hospital in Dubai in a six month - period. The analysis shows an increased prevalence of Low Density Lipoprotein (LDL) hypercholesterolemia with relatively higher Low Density Lipoprotein Cholesterol (LDL-c) values in male subjects (p<0.016) as well as with the Middle East ethnic origin group (p<0.025), while desirable High Density Lipoprotein (HDL-c) was found among female subjects (p=0). The discordance between the percentages of elevated LDL-c and Total cholesterol (T-c) signifies the role of the LDL-c/non-HDL-c as the main surrogate for dyslipidaemia as a risk for atherosclerosis, and as a primary target of therapy.
引用
收藏
页码:1087 / 1092
页数:6
相关论文
共 21 条
  • [1] [Anonymous], CHANGING DEMOGRAPHIC
  • [2] CARLSON LA, 2003, SECONDARY PREVENTION
  • [3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [4] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
    Downs, JR
    Clearfield, M
    Weis, S
    Whitney, E
    Shapiro, DR
    Beere, PA
    Langendorfer, A
    Stein, EA
    Kruyer, W
    Gotto, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622
  • [5] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND CARDIOVASCULAR-DISEASE - 4 PROSPECTIVE AMERICAN-STUDIES
    GORDON, DJ
    PROBSTFIELD, JL
    GARRISON, RJ
    NEATON, JD
    CASTELLI, WP
    KNOKE, JD
    JACOBS, DR
    BANGDIWALA, S
    TYROLER, HA
    [J]. CIRCULATION, 1989, 79 (01) : 8 - 15
  • [6] Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001
  • [7] HASAB AAH, SITUATIONAL ANAL FUT
  • [8] FACTORS OF RISK IN DEVELOPMENT OF CORONARY HEART DISEASE - 6-YEAR FOLLOW-UP EXPERIENCE
    KANNEL, WB
    KAGAN, A
    STOKES, J
    DAWBER, TR
    REVOTSKIE, N
    [J]. ANNALS OF INTERNAL MEDICINE, 1961, 55 (01) : 33 - +
  • [9] Global burden of diabetes, 1995-2025 - Prevalence, numerical estimates, and projections
    King, H
    Aubert, RE
    Herman, WH
    [J]. DIABETES CARE, 1998, 21 (09) : 1414 - 1431
  • [10] Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations
    Kuulasmaa, K
    Tunstall-Pedoe, H
    Dobson, A
    Fortmann, S
    Sans, S
    Tolonen, H
    Evans, A
    Ferrario, M
    Tuomilehto, J
    [J]. LANCET, 2000, 355 (9205) : 675 - 687